Pharmidex partners in European Commission H2020 award
May 21, 2017

Pharmidex joins Horizon 2020 EU project to work on radioactive contamination

Pharmidex partners in European Commission H2020 award

This project aims to stimulate intersectoral and international collaboration within Europe and with an ICPC country, Kazakhstan, in the area of novel nanoporous and nanostructured adsorbents for the treatment of very serious health conditions associated with acute and chronic exposure to external radiation and uptake of heavy metals and radiation as a consequence of accidental, occupational or deliberate activities and events.


This can dramatically lower the quality of life of the people affected and at present the treatment available is costly and inefficient. Radioactive contamination is a particularly serious problem in two of the countries participating in this project, namely, Ukraine and Kazakhstan, on large territories of the Chernobyl zone and around Semipalatinsk nuclear test site, respectively.


A large number of people are affected by living in the areas with elevated level of radioactivity with uncertain long-term consequences to their health and the health of future generations.


The expected impact of the project results is development of efficient and cost-effective methods of protection of first responders, population and cancer patients treated with radiotherapy from elevated doses of external and incorporated radiation and for occupational health protection of personnel working and the population living in areas contaminated with heavy metals.


Please find more information on the following web page: http://cordis.europa.eu/project/rcn/207057_en.html

January 5, 2026
We’re excited to expand our Bioanalytical team and are currently recruiting for two on-site, full-time roles supporting regulated and non-regulated programmes across small and large molecules: 1 - Technical Specialist, Bioanalysis (LC-MS) This is a senior technical authority role for an experienced LC-MS/MS scientist who enjoys solving complex analytical challenges and shaping technical direction. You’ll lead advanced method development and validation, support regulated studies, and mentor other scientists within a collaborative CRO environment. Ideal for candidates with: 5+ years of hands-on LC-MS/MS bioanalytical experience Strong expertise in method development, validation, and troubleshooting Experience with peptides, oligonucleotides, and large molecules Solid knowledge of GLP/GCP bioanalysis CRO experience (strongly preferred) 2 - Bioanalytical Scientist (Regulatory Studies) This role suits a hands-on bioanalytical scientist with experience delivering high-quality data for GLP/GCP studies. You’ll be involved across the full bioanalytical workflow, from method development to reporting, working closely with internal teams and (depending on experience) clients. Ideal for candidates with: A degree in Chemistry or a related discipline 5+ years’ experience in a bioanalytical laboratory Proven experience supporting GLP and/or GCP studies Strong LC-MS, sample preparation, and large-molecule expertise Experience with peptides and oligonucleotides โœจ Why Pharmidex? At Pharmidex, you’ll join a science-driven CRO where quality, accountability, and technical excellence matter. These roles offer real impact, strong collaboration, and the opportunity to contribute to diverse therapeutic programmes. ๐Ÿ“ฉ Interested? Please, check the full offers detail at https://www.pharmidex.com/careers-at-pharmidex and send your CV and a short cover note to [email protected] Feel free to share or tag anyone who might be a great fit!
December 31, 2025
As we step into 2026, we’re proud to continue supporting our clients with local UK expertise delivered at an international scale. At Pharmidex , we support programmes from discovery through to IND-enabling studies, helping teams progress confidently from concept to clinic. With integrated in vivo, bioanalysis and translational capabilities, everything is delivered under one roof in the UK, ensuring quality, continuity and efficiency at every stage. 2025 was one of the most challenging years our industry has faced, yet together we continued to deliver meaningful science, supporting nearly 1,000 projects and contributing to medicines that make a real difference to patients’ lives. Thank you to our clients and partners for your continued trust. We look forward to supporting innovation and high-quality science in the year ahead.
December 24, 2025
As we come to the end of the year, we would like to wish everyone a very Happy Christmas and a healthy, successful New Year. 2025 has been a hugely rewarding year for the Pharmidex team. We’re proud to have supported close to 1,000 projects, working alongside innovative companies across pharma and biotech to help advance new ideas, technologies, and programmes. Thank you to our clients, collaborators, and partners for trusting us to be part of your journey. We look forward to continuing to support even more projects and working together in the year ahead. From everyone at Pharmidex , Merry Christmas and see you in the New Year! ๐ŸŽ„โœจ
More Posts